Jubilant Life Sciences in a regulatory filing said it has been informed by the US Food and Drug Administration (USFDA) that inspection from December 10-18, 2018 at the Jubilant Generics Ltd API manufacturing facility, in Nanjangud, Mysore, has been classified as #39;Official Action Indicated#39; (OAI).USFDA classifies Jubilant Life#39;s Nanjangud facility as #39;Official Action Indicated#39;
Jubilant Life Sciences in a regulatory filing said it has been informed by the US Food and Drug Administration (USFDA) that inspection from December 10-18, 2018 at the Jubilant Generics Ltd API manufacturing facility, in Nanjangud, Mysore, has been classified as #39;Official Action Indicated#39; (OAI).
Subscribe to:
Post Comments (Atom)
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
-
"Paytm is now empowering feature phone users to recharge for their Vodafone Idea numbers with just a valid UPI ID. Along with the tele...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
No comments:
Post a Comment